Skip to main content

Beneficial ownership — 13D / 13G

87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
JEFF TOGHRAIE AXIL Axil Brands, Inc. 13D 46.3% 2y
Saba Capital Management, L.P. ASGI abrdn Global Infrastructure Income Fund 13D/A 10.31% 2y
Silver Point Capital L.P. GPOR Gulfport Energy Corp 13D/A 34.7% 2y
Runa Capital Opportunity I (GP) MRDB MariaDB plc 13D/A 8.7% 2y
GIC Private Ltd UXIN Uxin Ltd 13G/A 11.93% 2y
JEFFERSON RIVER CAPITAL LLC RNLXY Renalytix plc 13D/A 7.1% 2y
PL Capital Advisors, LLC FNWD Finward Bancorp 13D 8.3% 2y
Cannae Holdings, Inc. SST System1, Inc. 13D/A 39.5% 2y
MILLENNIUM MANAGEMENT LLC MGEE Mge Energy Inc 13G 0.1% 2y
Stuart D. Porter AIRJ AirJoule Technologies Corp. 13D 38.9% 2y
Matthew Jore AIRJ AirJoule Technologies Corp. 13D 14.3% 2y
Patrick C. Eilers AIRJ AirJoule Technologies Corp. 13D 22% 2y
NEEDHAM INVESTMENT MANAGEMENT LLC ASUR Asure Software Inc 13G 5.15% 2y
DC VGA LLC TBCH Turtle Beach Corp 13D 19.6% 2y
Amster Howard WHLR Wheeler Real Estate Investment Trust, Inc. 13D/A 14.76% 2y
GAMCO INVESTORS, INC. ET AL GYRO Gyrodyne, LLC 13D/A 10% 2y
Capital Ventures International NN Nextnav Inc. 13G 5.1% 2y
Cormorant Asset Management, LP VTYX Ventyx Biosciences, Inc. Common Stock 13G 5.21% 2y
Commodore Capital LP DFTX Definium Therapeutics, Inc. 13G 8.3% 2y
WOLVERINE ASSET MANAGEMENT LLC MCAA Mountain & Co. I Acquisition Corp. Class A Ordinary Shares 13G/A 0% 2y
Vector Acquisition Partners II, L.P. VAQC Vector Acquisition Corporation II Class A Ordinary Shares 13G/A 0% 2y
Tony L. Alford LCU Lion Copper Corp. 13D/A 31.7% 2y
Matthew Hulsizer OKLO Oklo Inc. 13G 0% 2y
Matthew Hulsizer AMOD Alpha Modus Holdings, Inc. 13G 0% 2y
Peter Thomas Smedvig LZM Lifezone Metals Ltd 13G 17.4% 2y
SIT INVESTMENT ASSOCIATES INC CEV Eaton Vance California Municipal Income Trust 13D 5.29% 2y
ILJIN SNT Co., Ltd. AUPH Aurinia Pharmaceuticals Inc. 13D/A 5.2% 2y
Schusterman Interests, LLC ROOT Root, Inc. 13G/A 3.2% 2y
GKCC, LLC ELTX Elicio Therapeutics, Inc. 13D/A 19.99% 2y
Investment Corporation of Dubai NDAQ Nasdaq, Inc. 13D/A 15.5% 2y
Imperial Petroleum Inc. CISS C3is Inc. 13D/A 74.8% 2y
Altria Group, Inc. BUD Anheuser-Busch InBev SA 13D/A 55.2% 2y
H&F Corporate Investors X, Ltd. SPLK Splunk Inc 13D/A 0% 2y
Cannae Holdings, Inc. DNB Dun & Bradstreet Holdings, Inc. 13D/A 15.7% 2y
Ruby Finance Holdings Ltd. QFIN Qfin Holdings, Inc. 13D/A 4.6% 2y
Gregory George MESO Mesoblast Ltd 13G/A 10.83% 2y
Casdin Capital, LLC LAB Standard Biotools Inc. 13D/A 19.25% 2y
GMS VENTURES & INVESTMENTS OTLK Outlook Therapeutics, Inc. 13D/A 37% 2y
Philotimo Fund, LP STKS ONE Group Hospitality, Inc. 13D/A 15.5% 2y
Cummins Inc. ATMU Atmus Filtration Technologies Inc. 13G/A 0% 2y
NOVO HOLDINGS A/S SPRB Spruce Biosciences, Inc. 13D/A 10.9% 2y
APA Corporation KNTK Kinetik Holdings Inc. 13D/A 0% 2y
HealthCap VII, L.P. FUSN Fusion Pharmaceuticals Inc. Common Shares 13D/A 4.5% 2y
VIKING GLOBAL INVESTORS LP LAB Standard Biotools Inc. 13G/A 15.3% 2y
McEwen David S KTEL KonaTel, Inc. 13D/A 37.6% 2y
Mango Shipping Corp. PSHG Performance Shipping Inc. 13D/A 66.4% 2y
Charles Frischer NN Nextnav Inc. 13D/A 6.8% 2y
Radoff Bradley Louis KVHI Kvh Industries Inc \De\ 13G 5.7% 2y
MILLENNIUM MANAGEMENT LLC BOX Box Inc 13G 0.5% 2y
PERCEPTIVE ADVISORS LLC RYTM Rhythm Pharmaceuticals, Inc. 13D 5.4% 2y